APOLLO THERAPEUTICS NO.2 LLP - CAMBRIDGE
| Company Profile | Company Filings |
Overview
APOLLO THERAPEUTICS NO.2 LLP is a Limited Liability Partnership from CAMBRIDGE UNITED KINGDOM and has the status: Dissolved - no longer trading.
APOLLO THERAPEUTICS NO.2 LLP was incorporated 8 years ago on 15/12/2015 and has the registered number: OC403442. The accounts status is FULL.
APOLLO THERAPEUTICS NO.2 LLP was incorporated 8 years ago on 15/12/2015 and has the registered number: OC403442. The accounts status is FULL.
APOLLO THERAPEUTICS NO.2 LLP - CAMBRIDGE
This company is listed in the following categories:
None Supplied
None Supplied
Accounts Status
| Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
|---|---|---|
| 31 / 12 | 31/12/2021 |
Registered Office
3RD FLOOR
CAMBRIDGE
CB1 2JD
UNITED KINGDOM
This Company Originates in : United Kingdom
Previous trading names include:
APOLLO THERAPEUTICS LLP (until 02/09/2021)
APOLLO THERAPEUTICS LLP (until 02/09/2021)
TRANSLATIONAL RESEARCH FUNDING LLP (until 03/02/2016)
Confirmation Statements
| Last Statement | Next Statement Due |
|---|---|
| 14/12/2022 | 28/12/2023 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
| Name | Born | Nationality | Role | Appointed | Status |
|---|---|---|---|---|---|
| AT BIDCO LIMITED | Corporate Llp Designated Member | 2021-06-16 | CURRENT | ||
| AT NO.1 LIMITED | Corporate Llp Member | 2021-06-16 | CURRENT | ||
| CAMBRIDGE ENTERPRISE LIMITED | Corporate Llp Designated Member | 2015-12-15 UNTIL 2021-06-16 | RESIGNED | ||
| UCL BUSINESS LTD | Corporate Llp Member | 2015-12-15 UNTIL 2021-06-16 | RESIGNED | ||
| JOHNSON & JOHNSON INNOVATION - JJDC INC. | Corporate Llp Member | 2015-12-15 UNTIL 2021-06-16 | RESIGNED | ||
| GLAXO GROUP LIMITED | Corporate Llp Member | 2015-12-15 UNTIL 2021-06-16 | RESIGNED | ||
| ASTRAZENECA UK LIMITED | Corporate Llp Member | 2015-12-15 UNTIL 2021-06-16 | RESIGNED | ||
| IMPERIAL INNOVATIONS LIMITED | Corporate Llp Designated Member | 2015-12-15 UNTIL 2021-06-16 | RESIGNED |